1. Home
  2. RGEN vs HBM Comparison

RGEN vs HBM Comparison

Compare RGEN & HBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • HBM
  • Stock Information
  • Founded
  • RGEN 1981
  • HBM 1927
  • Country
  • RGEN United States
  • HBM Canada
  • Employees
  • RGEN N/A
  • HBM N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • HBM Metal Mining
  • Sector
  • RGEN Health Care
  • HBM Basic Materials
  • Exchange
  • RGEN Nasdaq
  • HBM Nasdaq
  • Market Cap
  • RGEN 6.5B
  • HBM 5.4B
  • IPO Year
  • RGEN N/A
  • HBM N/A
  • Fundamental
  • Price
  • RGEN $152.80
  • HBM $16.43
  • Analyst Decision
  • RGEN Buy
  • HBM Strong Buy
  • Analyst Count
  • RGEN 11
  • HBM 1
  • Target Price
  • RGEN $167.90
  • HBM $19.50
  • AVG Volume (30 Days)
  • RGEN 972.1K
  • HBM 9.5M
  • Earning Date
  • RGEN 10-28-2025
  • HBM 11-12-2025
  • Dividend Yield
  • RGEN N/A
  • HBM 0.09%
  • EPS Growth
  • RGEN N/A
  • HBM 216.33
  • EPS
  • RGEN N/A
  • HBM 0.72
  • Revenue
  • RGEN $673,956,000.00
  • HBM $2,202,000,000.00
  • Revenue This Year
  • RGEN $16.77
  • HBM $13.99
  • Revenue Next Year
  • RGEN $13.79
  • HBM N/A
  • P/E Ratio
  • RGEN N/A
  • HBM $22.40
  • Revenue Growth
  • RGEN 8.73
  • HBM 8.31
  • 52 Week Low
  • RGEN $102.97
  • HBM $5.95
  • 52 Week High
  • RGEN $182.52
  • HBM $17.73
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 65.63
  • HBM 61.07
  • Support Level
  • RGEN $143.47
  • HBM $16.57
  • Resistance Level
  • RGEN $157.03
  • HBM $17.65
  • Average True Range (ATR)
  • RGEN 6.17
  • HBM 0.66
  • MACD
  • RGEN 0.64
  • HBM -0.04
  • Stochastic Oscillator
  • RGEN 87.20
  • HBM 54.31

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About HBM Hudbay Minerals Inc. (Canada)

Hudbay Minerals Inc is a Canadian mining company with its operations, property developments, and exploration activities across the United States. The mines that Hudbay operates are located in Manitoba, Canada, Arizona, United States; and Peru. The company is principally focused on the discovery, production, and marketing of base and precious metals. Hudbay produces copper concentrate, which contains copper, gold, and silver, as well as zinc metal. More than half the company's revenue is attributable to the copper business. The company sells copper concentrates to smelters across Asia, America, and Europe, and sells Zinc metal, another source of revenue, to industrial customers across North America.

Share on Social Networks: